Immune thrombocytopenic purpura ITP

Vox Sanguinis

Volumn 74, Issue SUPPL. 2, 1998, Pages 309-314

  Imbach, P ^a   Kuhne T ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; HLA DR ANTIGEN; INTERLEUKIN 2;

BLEEDING; CONFERENCE PAPER; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; THROMBOCYTE COUNT;

EID: 0031818748     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1423-0410.1998.tb05436.x     Document Type: Conference Paper

References (64)

1. Jones HW, Tocantins LM. The history of purpura hemorrhagica. Ann Med Hist 1933; 5:349.
2. Kasnelson P. Verschwinden der hämorrhagischen Diathese bei einem Falle von essentieller Thrombopenie (Frank) nach Milzexstirpation. Wein Klin Wochenschr 1916;29:1451.
3. Harrington WJ, Minnich V. Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura. J Lab Clin Med 1951;38:1-10.
4. Shulman NR, Marder VJ, Weinrach RS. Similarities between known antiplatelet antibodies and the factor responsible for thrombocytopenia in idiopathic purpura: physiologic, serologic and isotopic studies. Ann NY Acad Sci 1965;124:499-542.
5. Dixon RH, Rosse WF. Platelet antibody in immune thrombocytopenia. Br J Haematol 1975;31:129-134.
6. Imbach P, d'Appuzzo V, Hirt A, Rossi E, Vest M, Barandun S, Baumgartner C, Morell A, Schoni M, Wagner HP. High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet 1981; 1:1228-1231.
7. van Leeuwen EF, van der Ven JTH, Engelfriet CP, von dem Borne AEG. Specificity of auto-antibodies in autoimmune thrombocytopenia. Blood 1982;59:23-26.
8. McMillan R, Tani P, Millard F, Berchtold L, Renshaw L, Woods VL. Platelet-associated and plasma anti-glycoprotein autoantibodies in chronic ITP. Blood 1987;70:1040-1045.
9. Kiefel V, Santoso S, Weisheit M, Mueller-Eckhardt C. Monolocal antibody-specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies. Blood 1987;70:1722-1726.
10. Lammi AT, Lovric VA. Idiopathic thrombocytopenic purpura: an epidemiologic study. J Pediatr 1973;83:31.
11. Lusher JM, Zuelzer WW. Idiopathic thrombocytopenic purpura in childhood. J Pediatr 1966;68:971.
12. Simons SM, Main CA, Yaish HM, et al. Idiopathic thrombocytopenic purpura in children. J Pediatr 1975;87:16.
13. Dameshek W, Ebbe S. Recurrent acute idiopathic thrombocytopenic purpura. N Engl J Med 1963;269:647.
14. Stuart MJ, Tomar RH, Miller ML et al. Chronic idiopathic thrombocytopenic purpura:a familial immunodeficiency syndrome? JAMA 1978;239:939.
15. Lightsey AL, Koenig HM, McMilan R, Stone JR. Platelet-associated immunglobulin G in childhood idiopathic thrombocytopenic purpura. J Pediatr 1979;94:201-204.
16. McIntosh S, Johnson C, Hartigan P et al. Immunoregulatory abnormalities in children with thrombocytopenic purpura. J Pediatr 1981;99:525.
17. Myllylä G, Vaheri A, Vesikari T et al. Interaction between human blood platelets, viruses and antibodies. IV. Post-rubella thrombocytopenic purpura and platelet aggregation by rubella antigen-antibody interaction. Clin Exp Immunol 1969;4:323.
18. Panel on diagnostic applications of radio-nuclides. Recommended method for indium111 platelet survival studies. J Nucl Med 1988;29:564-566.
19. Schmidt KG, Rasmussen JW. Kinetics and distribution in vivo of 111-In-labeled autologus platelets in idiopathic thrombocytopenic purpura. Scand J Haematol 1985;34:47-56.
20. Ballem PJ, Segal GM, Stratton JR, Gernsheimer T, Adamson JW, Slichter S. Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura. Evidence for both impaired platelet production and increased platelet clearance. J Clin Invest 1987; 80:33-40.
21. McMillan R, Longmire RL, Yelenosky R, Donnell RL, Armstrong S. Quantitation of platelet-binding IgG produced in vitro by spleens from patients with idiopathic thrombocytopenic purpura. N Engl J Med 1974; 291:812-817.
22. McMillan R, Yelenosky RJ, Longmire RL. Antiplatelet antibody production bythe spleen and bone marrow in immune thrombocytopenic purpura. In: Battisto JR, Streinlein JW, eds. Immunoaspects of the spleen. North Holland Biomedical Press, Amsterdam 1976;227-237.
23. McMillan R, Luiken GA, Levy R, Yelenosky R, Longmire RL. Antibody against megakaryocytes in idiopathic thrombocytopenic purpura. JAMA 1978;239:2460-2462.
24. Heyns AP, Bdenhorst PN, Letter MG, Pieters H, Wessels P, Kotze HF. Platelet turnover and kinetics in immune thrombocytopenic purpura: Results with autologus 111-In-labeled and homologous 51-Cr-labeled platelets differ. Blood 1986;67:86-92.
25. Stoll D, Cines DB, Aster RH, Murphy S. Platelet kinetics in patients with idiopathic thrombocytopenic purpura and moderate thrombocytopenia. Blood 1985;65:584-588.
26. Kiefel V, Santoso S, Kaufmann E et al. Auto-antibodies against platelet glycoprotein Ib/IX: a frequent finding in autoimmune thrombocytopenic purpura. Br J Haematol 1991; 79:256-262.
27. McMillan R. Antigen-specific assays in immune thrombocytopenic. Trans Med Rev. 1990;4:136-143.
28. Koerner TAW, Weinfeld HM, Bullard LSB, Williams LCJ. Antibodies against platelet glycosphingolipids: detection in serum by quantitative HPTLC-autoradiography and association with autoimmune and alloimmune processes. Blood 1989;74:274-284.
29. Imbach P, Tani P, Berchtold W, Blanchette V, Burck-Kozlowska A, Gerber H, Jacobs P, Newland A, Turner C, Wood L. Different forms of chronic ITP in children defined by antiplatelet autoantibodies. J Pediatr 1991; 118:535-539.
30. Semple JW;, Freedman J: Abnormal cellular immune mechanisms associated with autoimmune thrombocytopenia. Trans Med Reviews 1995;4:327-338.
31. Boshkov LK, Kelton JG, Halloran PF. HLADR expression by platelets in acute idiopathic thromocytopenic purpura. Br J Heamatol 1992;81:552-557.
32. Semple JW, Milev Y, Cosgrave D, Mody M, Hornstein A, Blanchette V, Freedman J. Differences in serum cytokine levels in acute and chronic autoimmune thrombocytopenic purpura: Relationship to platelet phenotype and antiplatelet T-Cell reactivity. Blood 1996; 87:4245-4254.
33. Santoso S, Kalb R, Kiefel V, Mueller-Eckhardt C.The presence of messenger RNA for HLA class I in human platelets and its capability for protein biosynthesis. Br J Haematol 1993:84:451.
34. Nepom G. Erlich H: MHC class-II molecules and autoimmunity. Annu Rev Immunol 1991; 9:493.
35. Bottazzo GF, Dean BM, McNally JM, Me Kay EH, Swift PGF, Gamble DR; In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetes mellitus. N Engl J Med 1985; 313:353.
36. Traugott U, Scheinberg LC, Raine CS. On the presence of Ia-positive endothelial cells and astrocytes in multiple sclerosis lesions and its relevance to antigen presentation. J Neuroimmuol 1985;8:1.
37. Trotter JL: Serial studies of serum interleukin-2 in chronic progressive multiple sclerosis patients: occurrence of bursts and effects of cyclosporine. J Neuroimmunol 1990;28:1.
38. Tebib JG, Boughaba H, Letroublon MC. Serum IL-2 level in reumatoid arthritis: Correlation with joint destruction and disease progression. Eur Cytokine Network 1991;2:239.
39. Huang Y-P, Perrin LH, Miescher PA, Zubler RH: Correlation of T and B cell activites in vitro and serum IL-2 levels in systemic lupus erythmatosus. J Immunol 1991;141:827.
40. DeFrance T, Vandeviliet B, Briere F, Durand I, Rousset F, Banchereau J: Interleukin 10 and transforming growth factor β cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A. J. Exp Med 1992;175:671.
41. Howard M, Muchamuel T, Audrade S, Mennon S. Anti-inflammatory effect of IL-10. J Exp Med 1993;177:1205.
42. Garcia-Suarez J,Prieto A, Reyes E, Manzano L, Arribalzago K, Alverez Mon M. Abnormal γ-IFN and αTNF secretion in purified CD2+ cells from autoimmune thrombocytopenic purpura (ATP) patients: Their implication in the clinical course of the disease. Am J Hematol 1995;49:271.
43. Kaplan C, Morinet F, Carton J: Virus-induced autoimmune thrombocytopenia and neutropenia. Semin Hematol 1992;1:34.
44. Woerner SJ, Abildgaard CF, French BN. Intracranial hemorrhage in children with idiopathic thromboxytopenic purpura. Pediatrics 1981;67:453.
45. Halperin DS, Doyle JJ. Is bone marrow examination justified in idiopathic thrombocytopenic purpura? Am J Dis Child 1988; 142:509.
46. Ramos MEG, Newman AJ, Gross S. Chronic thrombocytopenia in childhood. J Pediatr 1978;92:584.
47. George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballem PJ, Blanchette VS, Bussel JB, Cines DB, Kelton JG, Lichtin AE, McMillan R, Okerbloom JA, Regan DH, Warrier I. Idiopathic thrombocytopenic purpura; A practice guidline developed by explicit methods for the American Society of Hematology, Blood 1996;88(1):3-40.
48. Tamary H, Kaplinsky C, Levy I, Cohen IJ, Yaniv I, Stark B, Goshen Y, Zaizov R. Chronic childhood idiopathic thrombocytopenia purpura: Long-term follow-up. Acta Paediatr 1994;83:931.
49. Reid MM. Chronic idiopathic thrombocytopenic purpura: incidence, treatment and out-come. Arch Dis Child 1995;72:125.
50. Andrew M, Blanchette VS, Adams M, Ali K, Barnard D, Chan KW, DeVeber LB, Esseltine D, Israels S, Korbinski N. A multicenter study of the treatment of childhood chronic idiopathic thrombocytopenic purpura with anti-D. J Pediatr 1991;120:522-527.
51. Proctor SJ, Jackson G, Carey P, Stark A, Finney R, Saunders P, Summerfield G, Maharaj D, Youart A. Improvement of platelet counts in steroid-unresponsive idiopathic immune thrombocytopenic purpura after short-course therapy with recombinant alpha 2b interferon. Blood 1989;74:1894-1897.
52. Sartorius JA. Steroid treatment of idiopathic thrombocytopenic purpura in children. Preliminary results of a randomized cooperative study. Am J Pediatr Hematol Oncol 1984; 6:165.
53. Ozsoylu S, Irken G, Karabent A. High-dose intravenous methylprednisolone for acute childhood idiopathic thrombocytopenic purpura. Eur J Haematol 1989;42:431.
54. Andersen JC. Response of resistant idiopathic thrombocytopenic purpura to pulsed high-dose demamethasone therapy. N Engl J Med 1994; 330:1560-1564.
55. Blanchette VS, Luke B, Anrew M, Sommerville-Nielsen S, Barnard D, De Veber B, Gent M. A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpura. J Pediatr 1993;123:989.
56. Blanchette V, Imbach P, Andrew M, Adams M, McMillan J, Wang E, Milner R, Ali K, Barnard D, Bernstein M, Chan KW, Esseltine D, DeVeber B, Israels S, Kobrinsky N, Luke B. Randomized trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura. Lancet 1994;344:703.
57. Schattner E, Bussel J, Mortality in immune thrombocytopenic purpura: Report of seven cases and consideration of prognostic indicators. Am J Heamtol 1994;46:120.
58. Imbach P, Akatsuka J, Blanchette V, Burek-Kozlowska A, Bussel J, Gaedicke G, Gianella-Borradori A, Gugler E, Hirt A, Imholz B, McMillan R, Morell A, Nugent D, Schöni MH, Wagner HP. Immunthrombocytopenic purpura as a model for pathogenesis and treatment of autoimmunity. Eur J Pediatr 1995;154(3):60-64.
59. Oezsoylu S. Treatment of chronic ITP. Pediatr Hematol Oncol 1995;12:407-408.
60. Aronis S, Platokouki H, Mitsika A, Haidas S, Constantopoulos A. Seventeen years of experience with chronic idiopathic thrombocytopenic purpura in childhood. Is therapy always better? Pediatr Hematol Oncol 1994;11:487-498.
61. Aronis S, Platokouki H, Mitsika A, Haidas S, Constantopoulos A. Treatment of chronic idopathic thrombocytopenic purpura. Pediatr Hematol Oncol 1995;12:409-410.
62. Imholz B, Imbach P, Baumgartner C, Berchtold W, Gaedicke G, Gugler E, Hirt A, Hitzig W, Mueller-Eckhardt C, Wagner HP. Intravenous immunoglobulin (i.v. IgG) for previously treated acute or for chronic idiopathic thrombocytopenic purpura (ITP) in childhood: A prospective multicenter study. Blut 1988;56:63.
63. Warrier IA, Lusher JM. Intravenous gamma-globulin (gamimune) for treatment of chronic idiopathic thrombocytopenic purpura (ITP): A two-year follow-up. Am J Hematol 1990;33: 184.
64. Nugent D, Wang Z, Sandborg C, Berman M. Reduced levels of JL-4 in immune mediated thrombocytopenia (ITP): role of cytokine imbalances in autoimmune disease. Immuno-hematology 1988:65a.